ESCROW AGREEMENTEscrow Agreement • May 15th, 2019 • Xynomic Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2019 Company Industry JurisdictionThis ESCROW AGREEMENT (this “Agreement”) is made and entered into as of May 13, 2019, by and among: (i) Bison Capital Acquisition Corp., a British Virgin Islands company which, prior to the consummation of the transactions contemplated by the Merger Agreement (as defined below), will domesticate as a Delaware corporation and, immediately thereafter will be known as “Xynomic Pharmaceuticals Holdings, Inc.” (“Parent”), (ii) Yinglin Mark Xu, solely in his capacity under the Merger Agreement as the Stockholder Representative (the “Stockholder Representative”); and (iii) Continental Stock Transfer & Trust Company, as escrow agent (the “Escrow Agent”). Capitalized terms used herein but not defined herein shall have the meanings given to such terms in the Merger Agreement (as defined below).
EXHIBIT H to Merger Agreement FORM OF ESCROW AGREEMENTEscrow Agreement • September 13th, 2018 • Bison Capital Acquisition Corp. • Blank checks • New York
Contract Type FiledSeptember 13th, 2018 Company Industry JurisdictionThis ESCROW AGREEMENT (this “Agreement”) is made and entered into as of [●], 2018, by and among: (i) Bison Capital Acquisition Corp., a British Virgin Islands company which, prior to the consummation of the transactions contemplated by the Merger Agreement (as defined below), will domesticate as a Delaware corporation and, immediately thereafter will be known as “Xynomic Pharmaceuticals Holdings, Inc.” (“Parent”), (ii) Yinglin Mark Xu, solely in his capacity under the Merger Agreement as the Stockholder Representative (the “Stockholder Representative”); and (iii) Continental Stock Transfer & Trust Company, as escrow agent (the “Escrow Agent”). Capitalized terms used herein but not defined herein shall have the meanings given to such terms in the Merger Agreement (as defined below).